SEC 13F Intelligence

Deerfield Management Company, L.P. / AMLX

Deerfield Management Company, L.P.’s Amylyx Pharmaceuticals Inc Position

Does Deerfield Management Company, L.P. own Amylyx Pharmaceuticals Inc (AMLX)? Not currently — the last reported position was 1.05M shares worth $23M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$23M
Q2 2023
Shares
1.05M
% of Portfolio
+0.48%
Quarters Held
3
position exited

Position History AMLX

Reported value by quarter
Q4 ’22: $100MQ4 ’22Q1 ’23: $58MQ1 ’23Q2 ’23: $23MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20231.05M$23M+0.48%
Q1 20231.98M$58M+1.30%
Q4 20222.69M$100M+2.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deerfield Management Company, L.P.’s full portfolio or all institutional holders of AMLX.